Curious to see your top suppliers emissions?
Book a demo for a pilot project
Genentech, a member of the Roche Group, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in South San Francisco, US. Founded in 1976, the company has pioneered advancements in biotechnology, focusing on the development of innovative medicines for serious medical conditions, particularly in oncology, immunology, and neuroscience.
With a strong commitment to research and development, Genentech has introduced several groundbreaking therapies, including targeted treatments that have transformed patient care. Its unique approach to drug development, emphasising personalised medicine, has solidified its position as a market leader. Notable achievements include being one of the first biotechnology companies to successfully bring a monoclonal antibody to market, setting a benchmark for the industry. Genentech continues to drive progress in healthcare, making significant contributions to the global pharmaceutical landscape.
48
DitchCarbon score
+8 vs industry average
Genentech’s score of 48 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genentech?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Genentech's reported carbon emissions
Genentech, a pharmaceutical preparation manufacturer headquartered in the US, reported total greenhouse gas emissions. For 2019, their total emissions were approximately 113,832,000 kg CO2e (market-based) and 140,550,000 kg CO2e (location-based). This included Scope 1 emissions of approximately 73,221,000 kg CO2e, Scope 2 emissions of approximately 63,436,000 kg CO2e (location-based), and Scope 3 emissions of approximately 73,600,000 kg CO2e.
In 2020, Genentech set a near-term target to achieve a 30% absolute reduction in CO2 emissions from their onsite energy use, compared to 2010 levels, by the year 2020.
Genentech's emissions data is cascaded, with the organisation being a current subsidiary. SBTi reduction targets are cascaded from Roche Holding AG.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genentech’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
2 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Inherited from Roche Holding AGSee details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Genentech18 days ago
48
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more